Bionik Laboratories Corp. announced the appointments of Audrey D. Thévenon, Ph.D. and Charles Matine to its Board of Directors. These appointments coincide with the resignation of directors Michal Prywata, effective September 7, 2018, and Marc Mathieu, effective August 1, 2018, and fill the two vacancies on the Board. Prywata will continue to contribute to the Board as an observer. With these changes Bionik has seven directors including four independent directors. Dr. Thévenon is a Program Officer on the Board of Life Sciences at The National Academies of Sciences, Engineering and Medicine, where she also serves as the Managing Editor of the journal Institute for Laboratory Animal Research. Matine is founder and CEO of B&Associates, a marketing and digital transformation company, and also is a strategic advisor to C4 Ventures and an Advisory Board Member for Enlaps. He previously spent eight years with Apple France where he led the Education and Research business unit, and Apple Europe, where he was responsible for promoting Apple products and defining marketing, PR and branding strategies within central Europe, the Middle East and Africa. Prior to Apple, Matine worked extensively in marketing and advertising, promoting technology products and brands throughout Europe. Matine was also appointed to the Audit Committee, chaired by Joseph Martin, while Dr. Thévenon was appointed to the Compensation Committee, chaired by Gerry Malone.